Suppr超能文献

“隐形人”:参与者在临床试验中的经历

"The invisible": Participant's experiences in clinical trials.

作者信息

Nadimpally Sarojini, Bhagianadh Divya

机构信息

Sama Resource Group for Women and Health, New Delhi, India.

出版信息

Perspect Clin Res. 2017 Jan-Mar;8(1):5-10. doi: 10.4103/2229-3485.198550.

Abstract

BACKGROUND

The paper discussing the perspectives of clinical trial participants about the various aspects of CTs is based on the primary research conducted by Sama in 2012-13.

METHODOLOGY

In-depth interviews were conducted with 36 CT participants from the states of New Delhi, Gujarat, Maharashtra and Andhra Pradesh. In addition to CT participants, other key informants including investigators, representatives of Contract Research Organizations (CROs), sponsor, Ethics Committee (EC) members etc. were also interviewed to develop a comprehensive understanding of the functioning of the CT sector.

FINDINGS AND DISCUSSION

The paper describes the perspectives of participants on the relevant aspects of recruitment into CTs, reasons for participation in CTs, informed consent, adverse events and compensation. The role played by the push and pull factors in recruitment, the information asymmetry, the power imbalance between the health-care provider and seeker, the role of sociocultural factors, etc., are explored in the paper. Combined with the insights from other stakeholders, the study gives an understanding about the chasm between regulations and realities in the Indian CT sector. Further, the paper briefly explores the recent changes and amendments in the laws governing the CT sector that is aimed at improving the conduct of CTs and uphold the rights of participants.

CONCLUSION

Participants are the most important stakeholders in a CT setting. It is imperative that their voices are heard and their rights upheld for the ethical conduct of CTs.

摘要

背景

本文讨论临床试验参与者对临床试验各个方面的看法,其基于萨马在2012 - 13年进行的初步研究。

方法

对来自新德里、古吉拉特邦、马哈拉施特拉邦和安得拉邦的36名临床试验参与者进行了深入访谈。除了临床试验参与者,还采访了其他关键信息提供者,包括研究者、合同研究组织(CRO)代表、申办方、伦理委员会(EC)成员等,以全面了解临床试验领域的运作情况。

研究结果与讨论

本文描述了参与者对临床试验招募的相关方面、参与临床试验的原因、知情同意、不良事件和补偿的看法。文中探讨了招募过程中推动和拉动因素所起的作用、信息不对称、医疗服务提供者与寻求者之间的权力不平衡、社会文化因素的作用等。结合其他利益相关者的见解,该研究揭示了印度临床试验领域法规与现实之间的差距。此外,本文简要探讨了近期临床试验领域相关法律的变化和修订,这些旨在改善临床试验的开展并维护参与者的权利。

结论

参与者是临床试验环境中最重要的利益相关者。必须倾听他们的声音并维护他们的权利,以确保临床试验符合伦理规范。

相似文献

9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验